Impact of Microvascular Inflammation on Kidney Allograft Outcome

Completed

Conditions studied: Transplant;Failure,Kidney, Kidney Transplant Rejection

In brief

Graft microvascular inflammation poses a significant challenge to successful kidney transplantation due to its heterogeneous clinical presentation. There is a critical need to unravel the clinical significance of newly defined allograft microvascular inflammation phenotypes in the Banff 2022 classification and assess the implications of these new phenotypes on kidney transplant precision diagnostics and patient risk stratification.

Key facts

Study ID
NCT06496269
Run by
Paris Translational Research Center for Organ Transplantation
People needed
6000
Starts
2023-01-01
Expected to finish
2023-12-31
Last updated by the study team
2024-07-11

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.